A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purposes of the study are to verify sufficient supplementation of luteal hormone after administrating FE999913 Vaginal Tablet twice a day (BID) or three times a day (TID) and to determine the efficacy and safety of FE999913 Vaginal Tablet in Japanese women undergoing fertility treatment with IVF-ET (a fresh embryo transfer).
Epistemonikos ID: 2ff2b8ff9a1482b8fb6a1a970aef9aa9ac4c8178
First added on: May 11, 2024